Thursday, January 20, 2022

SWEEGEN ALL PRAISE FOR NEW STEVIA TECHNOLOGY FRAMEWORK BY CODEX

KUALA LUMPUR, Jan 20 (Bernama) -- Sweegen’s health and wellness commitment through global sugar reduction solutions became stronger after Codex Alimentarius (Codex), the international food standard safety authority, recently adopted the specifications for all four stevia technologies, including Sweegen’s bioconversion.

“We welcome the adoption of the Codex framework and the opportunity to support our customers globally with new sugar reduction innovations,” said Steven Chen, Sweegen’s chief executive officer.

“Sweegen is proud to be part of this collaborative effort to bring much-needed innovation to the food and beverage industry,” he said in a statement.

The significance of the adoption is that there is now a more streamlined approach to regional adoption of new production technologies, providing greater access to less common and better-tasting steviol glycosides at scale and a more sustainable supply of the sugar-like tasting ingredients.

“With this framework, most countries in the world will gradually adopt this standard, and our global stevia footprint can expand more rapidly into countries where we are seeking approval for offering our pure, clean, and great-tasting Signature Bestevia ingredients produced by bioconversion,” said Luca Giannone, senior vice president of sales.

Sweegen’s support for adopting the ‘Framework for Stevia Technology’ started four years ago as a member of the alliance group, the International Stevia Council (ISC). Adopting the framework was a stevia industry effort and collaboration internationally where Sweegen represented bioconversion technology.

Under the new framework, all of Sweegen’s rebaudiosides are approved by Codex.

Last year, Sweegen earned regulatory approval for its Signature Bestevia Reb M in Europe, which enables greater flexibility in satisfying regional preferences for sweetness and great taste.

More details at www.sweegen.com.

-- BERNAMA

No comments:

Post a Comment